Literature DB >> 12937305

Glomerular and renal vascular structural changes in alpha8 integrin-deficient mice.

Christian S Haas1, Kerstin Amann, Johannes Schittny, Barbara Blaser, Ulrich Müller, Andrea Hartner.   

Abstract

Integrins are matrix receptors that regulate cell-matrix interactions during development and in adult tissue. In the adult kidney, the alpha8 chain is specifically expressed in glomerular mesangial cells and vascular smooth muscle cells. alpha8-deficient (alpha8-/-) mice demonstrate reductions in renal mass, which can range from complete renal agenesis to the development of kidneys that are only slightly smaller than wild-type kidneys. No histologic abnormalities of these kidneys have been described. However, considering the prominent expression of alpha8 in glomeruli and renal vessels, it seemed unlikely that the kidneys of alpha8-/- mice would be completely normal. Therefore, the renal phenotype of adult alpha8-/- mice was investigated, for assessment of more subtle morphologic alterations in kidney tissue. alpha8-/- mice displayed a significant reduction in nephron number and an increase in glomerular volume, compared with wild-type control animals. Albuminuria was not different in wild-type and alpha8-/- mice. Quantitative morphologic analyses revealed that the glomeruli of alpha8-/- mice were hypercellular, with an increased number of mesangial cells, compared with wild-type mice. Mesangial matrix deposition (as demonstrated for collagen IV and the alpha8 ligand fibronectin) was expanded in alpha8-/- mice, compared with wild-type mice. Collagens I and III, which are not normally present in glomeruli, were detected in the glomeruli of alpha8-/- mice. Staining for other glomerular integrins demonstrated an increased abundance of the collagen receptor alpha2 integrin in alpha8-/- mice. The glomerular capillary length density was significantly greater in alpha8-/- mice than in wild-type mice. Cortical arterial vessel walls were not altered in alpha8-/- mice, but the capillaries of the peritubular network were widened. Despite the strong mesangial and vascular expression of alpha8, glomerular and renal vascular alterations in alpha8-/- mice were relatively mild. Only aged alpha8-/- mice demonstrated increased glomerular capillary widening, compared with control animals. The results suggest that the lack of alpha8 can be largely compensated for, at least in younger alpha8-/- mice. It is not yet clear whether the occurrence of collagens that are not normally present in glomeruli and the increased abundance of the collagen receptor alpha2 contribute to maintaining the glomerular structure in alpha8-/- mice. The compensatory mechanisms involved will be the subject of future research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937305     DOI: 10.1097/01.asn.0000082999.46030.fe

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

Review 1.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

2.  Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression.

Authors:  Longxuan Li; Jennifer V Welser; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

3.  Mesangial cell αvβ8-integrin regulates glomerular capillary integrity and repair.

Authors:  Sujata Lakhe-Reddy; Vincent Li; Thomas D Arnold; Shenaz Khan; Jeffrey R Schelling
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-16

4.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

5.  No juvenile arterial hypertension in sheep multiples despite reduced nephron numbers.

Authors:  Anja Mühle; Christiane Mühle; Kerstin Amann; Jörg Dötsch; Kai-Dietrich Nüsken; Johannes Boltze; Holm Schneider
Journal:  Pediatr Nephrol       Date:  2010-04-13       Impact factor: 3.714

6.  Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction.

Authors:  Matthias R Meyer; Kerstin Amann; Angela S Field; Chelin Hu; Helen J Hathaway; Nancy L Kanagy; Mary K Walker; Matthias Barton; Eric R Prossnitz
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

7.  Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice.

Authors:  Jolanta E Pitera; Adrian S Woolf; Nicholas W Gale; George D Yancopoulos; Hai Tao Yuan
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).

Authors:  Anne Kosfeld; Martin Kreuzer; Christoph Daniel; Frank Brand; Anne-Kathrin Schäfer; Alexandra Chadt; Anna-Carina Weiss; Vera Riehmer; Cécile Jeanpierre; Michael Klintschar; Jan Hinrich Bräsen; Kerstin Amann; Lars Pape; Andreas Kispert; Hadi Al-Hasani; Dieter Haffner; Ruthild G Weber
Journal:  Hum Genet       Date:  2015-11-16       Impact factor: 4.132

9.  Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

Authors:  Oliver Jung; Felix Jansen; Anja Mieth; Eduardo Barbosa-Sicard; Rainer U Pliquett; Andrea Babelova; Christophe Morisseau; Sung H Hwang; Cindy Tsai; Bruce D Hammock; Liliana Schaefer; Gerd Geisslinger; Kerstin Amann; Ralf P Brandes
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

10.  The role of integrin alpha8beta1 in fetal lung morphogenesis and injury.

Authors:  John T Benjamin; David C Gaston; Brian A Halloran; Lynn M Schnapp; Roy Zent; Lawrence S Prince
Journal:  Dev Biol       Date:  2009-09-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.